Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fertility preservation in patients receiving chemotherapy or radiotherapy.

Literature DB >> 25438367

Fertility preservation in patients receiving chemotherapy or radiotherapy.

Abstract

The preservation and restoration of fertility are key aspects for enhancing quality of life in cancer survivors. Cytotoxic agents and radiation can produce gonadal dysfunction in both men and women. Survival rates for cancers that occur before or during reproductive age have improved dramatically. Current fertility preservation options are available but limited in males and females. Referral to a reproductive endocrinologist around the time of diagnosis is important to optimize treatment options.

Entities: Disease Species

Mesh：

Substances：
Cytotoxins

Year: 2014 PMID： 25438367 PMCID： PMC6172082

Source DB: PubMed Journal: Mo Med ISSN： 0026-6620

26 in total

1. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion.

Authors:
Journal: Fertil Steril Date: 2013-10-02 Impact factor: 7.329

2. Cyclophosphamide-induced ovarian failure.

Authors: G L Warne; K F Fairley; J B Hobbs; F I Martin
Journal: N Engl J Med Date: 1973-11-29 Impact factor: 91.245

3. Having children after cancer. A pilot survey of survivors' attitudes and experiences.

Authors: L R Schover; L A Rybicki; B A Martin; K A Bringelsen
Journal: Cancer Date: 1999-08-15 Impact factor: 6.860

4. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

Authors: Bernd Gerber; Gunter von Minckwitz; Heinrich Stehle; Toralf Reimer; Ricardo Felberbaum; Nikolai Maass; Dorothea Fischer; Harald L Sommer; Bettina Conrad; Olaf Ortmann; Tanja Fehm; Mahdi Rezai; Keyur Mehta; Sibylle Loibl
Journal: J Clin Oncol Date: 2011-05-02 Impact factor: 44.544

Review 5. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.

Authors: Mohamed A Bedaiwy; Ahmed M Abou-Setta; Nina Desai; William Hurd; David Starks; Sherif A El-Nashar; Hesham G Al-Inany; Tommaso Falcone
Journal: Fertil Steril Date: 2010-12-10 Impact factor: 7.329

Review 6. Ovarian function preservation in the cancer patient.

Authors: Tommaso Falcone; Marjan Attaran; Mohamed A Bedaiwy; Jeffery M Goldberg
Journal: Fertil Steril Date: 2004-02 Impact factor: 7.329

7. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial.

Authors: Eman A Elgindy; Dahlia O El-Haieg; Ola M Khorshid; Eman I Ismail; Mohamed Abdelgawad; Hassan N Sallam; Ahmed M Abou-Setta
Journal: Obstet Gynecol Date: 2013-01 Impact factor: 7.661

8. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.

Authors: A Sverrisdottir; M Nystedt; H Johansson; T Fornander
Journal: Breast Cancer Res Treat Date: 2009-01-20 Impact factor: 4.872

4. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.

Authors: Li Ling; Xiushan Feng; Tianqin Wei; Yan Wang; Yaping Wang; Ziling Wang; Dongyuan Tang; Yanjing Luo; Zhengai Xiong
Journal: Stem Cell Res Ther Date: 2019-01-25 Impact factor: 6.832

4 in total

Fertility preservation in patients receiving chemotherapy or radiotherapy.

1. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion.

2. Cyclophosphamide-induced ovarian failure.

3. Having children after cancer. A pilot survey of survivors' attitudes and experiences.

4. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

Review 5. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.

Review 6. Ovarian function preservation in the cancer patient.

7. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial.

8. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.

Review 9. Pediatric fertility preservation: is it time to offer testicular tissue cryopreservation?

Review 10. Fertility preservation in women of reproductive age with cancer.

1. A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.

2. Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage.

3. Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model.

4. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.